Dr. Nafisa Abdelhafeez

panellist

Dr. Nafisa Abbas Hassan Abdel Hafiez
MBB, MRCPI
ADULT MEDICAL ONCOLOGY FELLOWSHIP January 2014
Consultant, Division of Adult Medical Oncology, Department of Oncology, KASCH, KAMC – Riyadh
Assistant Professor of Medical Oncology, King Saud Bin Abdulaziz University

16:45-17:30

Friday 3-5-2024 Day 1

Transition from hormonal-based to chemotherapy in metastatic BC??

Patients with early progression on CDK4-6 inhibitors: What is next??
When to start ADCs/olaparib in patients who had visceral crisis?? Can be upfront??
Any role of hormonal monotherapy after CDK4-6 inhibitors??
Biomarkers to guide subsequent therapies
Can we use one ADC after previous ADC??

Moderator: Dr. Ahmed Alfaraj

Panel: